Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

233 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Oral insulin reloaded: a structured approach.
Zijlstra E, Heinemann L, Plum-Mörschel L. Zijlstra E, et al. J Diabetes Sci Technol. 2014 May;8(3):458-65. doi: 10.1177/1932296814529988. Epub 2014 Apr 7. J Diabetes Sci Technol. 2014. PMID: 24876606 Free PMC article. Review.
Similar risk of exercise-related hypoglycaemia for insulin degludec to that for insulin glargine in patients with type 1 diabetes: a randomized cross-over trial.
Heise T, Bain SC, Bracken RM, Zijlstra E, Nosek L, Stender-Petersen K, Rabøl R, Rowe E, Haahr HL. Heise T, et al. Among authors: zijlstra e. Diabetes Obes Metab. 2016 Feb;18(2):196-9. doi: 10.1111/dom.12588. Epub 2015 Nov 27. Diabetes Obes Metab. 2016. PMID: 26450456 Free PMC article. Clinical Trial.
Euglycaemic glucose clamp: what it can and cannot do, and how to do it.
Heise T, Zijlstra E, Nosek L, Heckermann S, Plum-Mörschel L, Forst T. Heise T, et al. Among authors: zijlstra e. Diabetes Obes Metab. 2016 Oct;18(10):962-72. doi: 10.1111/dom.12703. Epub 2016 Jul 13. Diabetes Obes Metab. 2016. PMID: 27324560 Review.
Pharmacological properties of faster-acting insulin aspart vs insulin aspart in patients with type 1 diabetes receiving continuous subcutaneous insulin infusion: A randomized, double-blind, crossover trial.
Heise T, Zijlstra E, Nosek L, Rikte T, Haahr H. Heise T, et al. Among authors: zijlstra e. Diabetes Obes Metab. 2017 Feb;19(2):208-215. doi: 10.1111/dom.12803. Epub 2016 Nov 14. Diabetes Obes Metab. 2017. PMID: 27709762 Free PMC article. Clinical Trial.
Pharmacokinetic and Pharmacodynamic Properties of Faster-Acting Insulin Aspart versus Insulin Aspart Across a Clinically Relevant Dose Range in Subjects with Type 1 Diabetes Mellitus.
Heise T, Stender-Petersen K, Hövelmann U, Jacobsen JB, Nosek L, Zijlstra E, Haahr H. Heise T, et al. Among authors: zijlstra e. Clin Pharmacokinet. 2017 Jun;56(6):649-660. doi: 10.1007/s40262-016-0473-5. Clin Pharmacokinet. 2017. PMID: 27878566 Free PMC article. Clinical Trial.
233 results